Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases
Saved in:
Main Authors: | Xiangke Xin, Wenli Zhang, Zhen Li, Ruirui Gui, Juan Wang, Liyun Ji, Yanli Zhang, Baijun Fang, Yongping Song, Yingling Zu, Jian Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-025-01218-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM
by: Krzysztof Kalwak, et al.
Published: (2025-02-01) -
Clinical utility of hematological parameters in aplastic anemia
by: Lizhong Zhang, et al.
Published: (2025-01-01) -
Dalla valorizzazione di un patrimonio proteiforme allo sviluppo territoriale: il turismo dell'olio
by: Julie Deramond, et al.
Published: (2024-07-01) -
Immunodeficiency, Centromeric Instability, and Facial Dysmorphism (ICF) Syndrome: How HSCT alters the impairment of the DNA methylation process
by: Wojciech Homa, et al.
Published: (2025-02-01) -
Evaluation of Hematological Parameters in Partial Exchange and Packed Cell Transfusion in Treatment of Severe Anemia in Pregnancy
by: Sudha Salhan, et al.
Published: (2012-01-01)